Knowde Enhanced TDS
Identification & Functionality
- Active Component
- Ingredient Name
- Ingredients
- Cranberry Extract
- Product Families
Features & Benefits
- Benefit Claims (Health)
- Food Ingredients Features
- Advantages
- The quantitative chemical characterization is based on the DMAC method, whereas the qualitative analysis isperformed by liquid chromatography coupled to mass spectrometry for the accurate identification and quantification Of PAC A
- The analytical methods used ensure a high quality of Oximacro bioactive Compounds
- The precise quantification allows the exact and reliable formulation of products t*sed on cran\xrry extracts for the treatment of UTI
- Oximacro contains the highest content Of PAC A titrated with the DMAC method present on the market
- Products Characteristic
The cranberry extract produced using a Biosfered Srl proprietary technology is first titrated with the DMAC method to obtain the total amount of PACs and subsequently is analyzed by liquid chromatography coupled to mass spectrometry (HPLC-ESI-MS/MS) for the assessment of the content of the PAC A (and the possible presence of PAC B).
Applications & Uses
- Applications
- Food & Nutrition Applications
Properties
Technical Details & Test Data
- Technical Info
Oximacro-FL
The liquid formulation allows the use of Oximacro in all fluid preparations. The high concentration of PAC A of the liquid extract allows reduction of the final product volume, while maintaining a high concentration of bioactive PAC A.Extractive technique
The extractive technique at low temperatures developed by Biosfered S.r.l. allows to obtain also in the dried extract an enrichment of the bioactive PAC A fraction.
The product is perfectly soluble in water and does not contain insoluble residues (e.g., maltodextrins, cell walls, etc..).
UTI and dosage of PACs
In humans, administration of a cranberry dried extract standardized in PACs (DMAC) at doses containing 72 mg of PAC per day, divided in two doses of 36 mg in the morning and evening, offers protection against bacterial adhesion and virulence in the urinary tract (Howell et al. BMC Infect. Dis. 2010, 10:94).